its pretty exciting to sit and watch a novel drug hit an arm for the first time. Even more exciting when you own a percentage of that new drug.
From the people who doodled an idea on a notepad many years ago, to the patient who hoping this new treatment works, to the share holder who sits back and watches as this all unfolds, its a pretty special occasion.
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-13
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(3.03%) |
Mkt cap ! $14.18M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.7¢ | 1.6¢ | $10.84K | 677.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1997996 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 245189 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| CHM (ASX) Chart |